Wednesday 21 November 2018
Home      All news      Contact us      Philipino
Channel News Asia - 3 month ago

Japan s Eisai gains US approval for liver cancer treatment

REUTERS: Japan s Eisai Co Ltd on Thursday received U.S. approval for a therapy for previously untreated patients with a common form of liver cancer, paving the way for multibillion dollar sales. The oral drug, Lenvima, was jointly developed with Merck and Co Inc to treat unresectable hepatocellular ...

Related news

Latest News
Hashtags:   

Japan

 | 

Eisai

 | 

gains

 | 

approval

 | 

liver

 | 

cancer

 | 

treatment

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources